These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14552764)

  • 1. A general synthesis of 1-aryl carbamoyl-2-alkyl-4-aryl substituted semicarbazides as nonbasic factor Xa inhibitors.
    Mederski WW; Germann M
    Bioorg Med Chem Lett; 2003 Nov; 13(21):3715-8. PubMed ID: 14552764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and structure-activity relationships of substituted piperazinone-based transition state factor Xa inhibitors.
    Su T; Yang H; Volkots D; Woolfrey J; Dam S; Wong P; Sinha U; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2003 Feb; 13(4):729-32. PubMed ID: 12639568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A four component coupling strategy for the synthesis of D-phenylglycinamide-derived non-covalent factor Xa inhibitors.
    Sheehan SM; Masters JJ; Wiley MR; Young SC; Liebeschuetz JW; Jones SD; Murray CW; Franciskovich JB; Engel DB; Weber WW; Marimuthu J; Kyle JA; Smallwood JK; Farmen MW; Smith GF
    Bioorg Med Chem Lett; 2003 Jul; 13(14):2255-9. PubMed ID: 12824013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic core.
    Fevig JM; Pinto DJ; Han Q; Quan ML; Pruitt JR; Jacobson IC; Galemmo RA; Wang S; Orwat MJ; Bostrom LL; Knabb RM; Wong PC; Lam PYS ; Wexler RR
    Bioorg Med Chem Lett; 2001 Mar; 11(5):641-5. PubMed ID: 11266160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological activity of novel non-amidine factor Xa inhibitors. Part 1: P(1) structure-activity relationships of the substituted 1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides.
    Jia ZJ; Wu Y; Huang W; Goldman E; Zhang P; Woolfrey J; Wong P; Huang B; Sinha U; Park G; Reed A; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2002 Jun; 12(12):1651-5. PubMed ID: 12039583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and SAR of amino acid derivatives as factor Xa inhibitors.
    Su T; Wu Y; Doughan B; Jia ZJ; Woolfrey J; Huang B; Wong P; Park G; Sinha U; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2001 Nov; 11(22):2947-50. PubMed ID: 11677132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-phase synthesis of N-substituted amidinophenoxy pyridines as factor XA inhibitors.
    Mohan R; Yun W; Buckman BO; Liang A; Trinh L; Morrissey MM
    Bioorg Med Chem Lett; 1998 Jul; 8(14):1877-82. PubMed ID: 9873451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and activity studies of conformationally restricted alpha-ketoamide factor Xa inhibitors.
    Cacciola J; Fevig JM; Stouten PF; Alexander RS; Knabb RM; Wexler RR
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1253-6. PubMed ID: 10866393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A general and efficient synthesis of pyridin-2-yl C-ribonucleosides bearing diverse alkyl, aryl, amino, and carbamoyl groups in position 6.
    Stefko M; Slavetínská L; Klepetárová B; Hocek M
    J Org Chem; 2010 Jan; 75(2):442-9. PubMed ID: 20000693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research or substances with antiviral action: carbamates, thiosemicarbazones and semicarbazones of cyclic alpha-oxyiminoketones].
    Giannella M; Gualtieri F
    Farmaco Sci; 1970 Jul; 25(7):509-18. PubMed ID: 5455045
    [No Abstract]   [Full Text] [Related]  

  • 11. The de novo design and synthesis of cyclic urea inhibitors of factor Xa: initial SAR studies.
    Galemmo RA; Maduskuie TP; Dominguez C; Rossi KA; Knabb RM; Wexler RR; Stouten PF
    Bioorg Med Chem Lett; 1998 Oct; 8(19):2705-10. PubMed ID: 9873607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and cytotoxicity of 7-deoxy aryl discodermolide analogues.
    Burlingame MA; Shaw SJ; Sundermann KF; Zhang D; Petryka J; Mendoza E; Liu F; Myles DC; LaMarche MJ; Hirose T; Scott Freeze B; Smith AB
    Bioorg Med Chem Lett; 2004 May; 14(9):2335-8. PubMed ID: 15081036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoisoquinolines: design and synthesis of an orally active benzamidine isostere for the inhibition of factor XA.
    Choi-Sledeski YM; Becker MR; Green DM; Davis R; Ewing WR; Mason HJ; Ly C; Spada A; Liang G; Cheney D; Barton J; Chu V; Brown K; Colussi D; Bentley R; Leadley R; Dunwiddie C; Pauls HW
    Bioorg Med Chem Lett; 1999 Sep; 9(17):2539-44. PubMed ID: 10498204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of factor Xa inhibitors and their prodrugs.
    Song Y; Clizbe L; Bhakta C; Teng W; Wong P; Huang B; Tran K; Sinha U; Park G; Reed A; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2003 Jan; 13(2):297-300. PubMed ID: 12482444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and structure-activity relationships of unsubstituted piperazinone-based transition state factor Xa inhibitors.
    Huang W; Naughton MA; Yang H; Su T; Dam S; Wong PW; Arfsten A; Edwards S; Sinha U; Hollenbach S; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2003 Feb; 13(4):723-8. PubMed ID: 12639567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amido-(propyl and allyl)-hydroxybenzamidines: development of achiral inhibitors of factor Xa.
    Gong Y; Pauls HW; Spada AP; Czekaj M; Liang G; Chu V; Colussi DJ; Brown KD; Gao J
    Bioorg Med Chem Lett; 2000 Feb; 10(3):217-21. PubMed ID: 10698439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, characterization, and structure-activity relationships of amidine-substituted (bis)benzylidene-cycloketone olefin isomers as potent and selective factor Xa inhibitors.
    Guilford WJ; Shaw KJ; Dallas JL; Koovakkat S; Lee W; Liang A; Light DR; McCarrick MA; Whitlow M; Ye B; Morrissey MM
    J Med Chem; 1999 Dec; 42(26):5415-25. PubMed ID: 10639283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selenium heterocycles. 8. Synthesis and antibacterial activity of selenosemicarbazide and 1,3,4-selenadiazolylcarbamic acid esters.
    Shafiee A; Lalezari I; Yazdany S; Pournorouz A
    J Pharm Sci; 1973 May; 62(5):839-40. PubMed ID: 4196206
    [No Abstract]   [Full Text] [Related]  

  • 19. Exploratory solid-phase synthesis of factor Xa inhibitors: discovery and application of p3-heterocyclic amides as novel types of non-basic arginine surrogates.
    Ho JZ; Levy OE; Gibson TS; Nguyen K; Semple JE
    Bioorg Med Chem Lett; 1999 Dec; 9(24):3459-64. PubMed ID: 10617091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and SAR of monobenzamidines and aminoisoquinolines as factor Xa inhibitors.
    Zhang P; Zuckett JF; Woolfrey J; Tran K; Huang B; Wong P; Sinha U; Park G; Reed A; Malinowski J; Hollenbach S; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2002 Jun; 12(12):1657-61. PubMed ID: 12039584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.